Drug name - Beyaz

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6441168 BAYER HLTHCARE Stable crystalline salts of 5-methyltetrahydrofolic acid
Jul, 2022

(2 months ago)

CN1154648C BAYER HLTHCARE 5-Stable Crystalline Calcium Salt Of Methyl Tetrahydrofolate And Preparation Method And Use Thereof
Apr, 2020

(2 years ago)

CN1277197A BAYER HLTHCARE Stable Crystalline Salt Of 5-Methyl Tetrahydrofolic Acid
Apr, 2020

(2 years ago)

EP1044975B1 BAYER HLTHCARE Stable Crystalline Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid
Apr, 2020

(2 years ago)

EP2189459A1 BAYER HLTHCARE Stable Crystalline Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid
Apr, 2020

(2 years ago)

EP2194057B1 BAYER HLTHCARE Stable Crystalline Calcium Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid
Apr, 2020

(2 years ago)

EP1044975A1 BAYER HLTHCARE Stable Crystalline Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid
Apr, 2020

(2 years ago)

EP2192120B1 BAYER HLTHCARE Stable Crystalline Calcium Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid
Apr, 2020

(2 years ago)

EP2189459B1 BAYER HLTHCARE Stable Crystalline Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid
Apr, 2020

(2 years ago)

EP2192120A1 BAYER HLTHCARE Stable Crystalline Calcium Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid
Apr, 2020

(2 years ago)

EP2194057A1 BAYER HLTHCARE Stable Crystalline Calcium Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid
Apr, 2020

(2 years ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8617597 BAYER HLTHCARE Pharmaceutical composition containing a tetrahydrofolic acid Feb, 2030

(7 years from now)

More Information on Dosage
Strength Dosage Availability
3MG,N/A;0.02MG,N/A;0.451MG,0.451MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.